Detalles de la búsqueda
1.
Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia.
Bioorg Med Chem
; 100: 117631, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330848
2.
Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia.
Drug Dev Res
; 84(2): 296-311, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36644989
3.
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia.
Bioorg Med Chem
; 70: 116937, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863236
4.
Development of Orally Active Thrombin Inhibitors for the Treatment of Thrombotic Disorder Diseases.
Molecules
; 20(6): 11046-62, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26083038
5.
Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.
Eur J Med Chem
; 271: 116435, 2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38648728
6.
Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.
J Med Chem
; 67(6): 4346-4375, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38484122
7.
Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II.
Future Med Chem
; 15(1): 57-71, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651264
8.
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia.
Biomed Pharmacother
; 169: 115905, 2023 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38000356
Resultados
1 -
8
de 8
1
Próxima >
>>